Chronic traumatic encephalopathy (CTE) is a progressive degenerative disease which afflicts the brain of people who have suffered repeated concussions and traumatic brain injuries, such as athletes who take part in contact sports, members of the military and others.

The brain of an individual who suffers from CTE gradually deteriorates and will over time end

Takeda, the manufacturer of Actos, has agreed to pay $nearly $2.4 billion to settle bladder cancer claims brought by users: 

  1. who  took Actos at some time prior to December 1, 2011,
  2. who were diagnosed with bladder cancer on or before April 28, 2015, and
  3. who retained counsel before May 1, 2015. Under the terms of

The law prohibits employers from making decisions regarding employees based upon protected classes. But what is a protected class?

Protected classes are certain categories of specific, personal characteristics. For example, gender is a protected class. That means, an employer may not make decisions regarding employees based upon the employee’s gender. An employer cannot fire, demote,

Takeda Pharmaceutical Co. the manufacture of Actos diabetes medicine has offered to pay more than $2.2 billion to resolve patients’ claims that the drug caused their cancer, according to Bloomberg News. More than 8,000 patients fighting bladder cancer have filed lawsuits in state and federal court. The settlement offer would pay each patient or his heirs

The risks of Propecia are still unfolding.  For several years, men have been taking Propecia for hair loss. Merck the manufacturer of Propecia represented that a limited number of users may experience side effects including sexual dysfunction such as decreased libido, erectile dysfunction and ejaculation disorder as well as potential depression. The actual rate of

Nearly 20,000 women have brought claims against Bayer for its failure to warn about Yaz’s association with increased risk of clotting.  Women suffered deep vein thromboses, pulmonary embolis and death.  Although Bayer has paid out approximately $1.7 billion in settlements to Yaz claimants approximately 3400 claims remain.

U.S. District Judge David Herndon expressed disappointment